首页> 外国专利> COLLOID SYNTHETIC VECTORS FOR GENE THERAPY

COLLOID SYNTHETIC VECTORS FOR GENE THERAPY

机译:用于基因治疗的胶体合成载体

摘要

Non-naturally occurring vector for gene therapy are provided, comprised of chemically defined reagents, where the vector is self-assembling and where the vector comprises (1) a core complex comprising a nucleic acid and (2) at least one complex forming reagent, where the vector has fusogenic activity. The vector optionally may contain reagents permitting fusion with cell membranes and nuclear uptake. The vector also may contain an outer shell moiety that is anchored to the core complex, whereby the outer shell stabilizes the complex, protects it from unwanted interactions and enhances delivery of the nucleic acid into a target tissue or cell. The outer shell optionally may be sheddable, that is, it may be designed such that it dissociates from the vector upon entry into the target cell or tissue.
机译:提供了用于基因治疗的非天然存在的载体,其由化学成分确定的试剂组成,其中所述载体是自组装的,并且其中所述载体包含(1)包含核酸的核心复合物和(2)至少一种形成复合物的试剂,载体具有融合活性的地方。载体可任选地包含允许与细胞膜融合和核吸收的试剂。载体还可以包含锚定至核心复合物的外壳部分,由此,外壳使复合物稳定,保护其免受有害相互作用并增强核酸向靶组织或细胞的递送。外壳可以任选地是可脱落的,也就是说,可以设计成使得外壳在进入靶细胞或组织中时与载体解离。

著录项

  • 公开/公告号IL150484B

    专利类型

  • 公开/公告日2010-12-30

    原文格式PDF

  • 申请/专利权人 NOVARTIS AG;

    申请/专利号IL150484

  • 发明设计人

    申请日2002-06-27

  • 分类号C12N15/09;A61K9/127;A61K31/519;A61K31/7088;A61K38/00;A61K38/27;A61K39/395;A61K47/14;A61K47/18;A61K47/22;A61K47/24;A61K47/28;A61K47/30;A61K47/34;A61K47/42;A61K47/44;A61K47/46;A61K48/00;A61P43/00;C07C215/14;C12N15/88;

  • 国家 IL

  • 入库时间 2022-08-21 18:06:30

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号